By designating just one reference listed drug as being the standard to which all generic versions need to be demonstrated to become bioequivalent, FDA hopes to avoid attainable sizeable variants amongst generic prescription drugs as well as their manufacturer name counterpart.Usually, the use of diazepam in Females of childbearing likely, and more